Selective serotonin reuptake inhibitor use in pregnancy and protective mechanisms in preeclampsia

HIGHLIGHTS

• who: Julie A. Vignato from the College of Nursing, University of Iowa, Iowa City, IA, USA have published the paper: Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia, in the Journal: (JOURNAL)
• what: The aim of this study was to investigate the associations among AVP secretion, depression symptoms, SSRIs, and preeclampsia during pregnancy to reveal the molecular basis for clinical depression-PreE links. In a large clinical dataset, the authors demonstrate that less preeclamptic women receive SSRI treatment. As a marker of AVP secretion, the authors demonstrate that maternal plasma copeptin . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.